<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944891/" ref="ordinalpos=3458&amp;ncbi_uid=2486304&amp;link_uid=PMC2944891" image-link="/pmc/articles/PMC2944891/figure/pone-0012968-g004/" class="imagepopup">Figure 4. bFGF <span class="highlight" style="background-color:">signaling</span> in chicken PGCs..  From: Basic Fibroblast Growth Factor Activates MEK/ERK Cell <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> and Stimulates the Proliferation of Chicken Primordial Germ Cells. </a></div><br /><div class="p4l_captionBody">(A) Activation of MAPK and PI3K/AKT signaling pathways by bFGF (10 ng·ml−1). NT: no treatment (B) Dose-dependent activation of MEK/ERK signaling by bFGF. NT: no treatment (C) Temporal effect of bFGF (10 ng·ml−1) on activation of MEK/ERK signaling. NT: no treatment (D) Inhibition of MEK/ERK signaling by a specific inhibitor of FGFRs (PD173074). NT: no treatment (E) Inhibition of ERK activation by PD0325901 in cultured PGCs (PD173074 was used as a control). (F) Cell recovery 4 days after PD0325901 treatment (mean ± SEM, n = 4). bFGF (10 ng·ml−1) was treated in all groups. Superscripts indicate significant differences between treatment groups (p&lt;0.05). Statistical analyses were conducted with ANOVA using SAS software. (G–H) Morphology of PGCs 4 days after treatment with PD0325901 (0.4 µM) (bar  = 100 µm). bFGF (10 ng·ml−1) was treated in all groups.</div></div>